Assessment of biotechnology drugs: what are the issues?

J.E.F. Zwart - van Rijkom, H.G.M. Leufkens, D.J.A. Crommelin, F. Rutten, A.W. Broekmans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)255-274
Number of pages20
JournalHealth Policy
Volume47
Publication statusPublished - 1999

Keywords

  • Epidemiology
  • Farmacie(FARM)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health

Cite this